220 related articles for article (PubMed ID: 23715050)
1. Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients.
Gaber AO; Alloway RR; Bodziak K; Kaplan B; Bunnapradist S
Transplantation; 2013 Jul; 96(2):191-7. PubMed ID: 23715050
[TBL] [Abstract][Full Text] [Related]
2. Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients.
Alloway RR; Eckhoff DE; Washburn WK; Teperman LW
Liver Transpl; 2014 May; 20(5):564-75. PubMed ID: 24493215
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of Once-Daily Extended-Release Tacrolimus Tablets Versus Twice-Daily Capsules in De Novo Liver Transplant.
DuBay DA; Teperman L; Ueda K; Silverman A; Chapman W; Alsina AE; Tyler C; Stevens DR
Clin Pharmacol Drug Dev; 2019 Nov; 8(8):995-1008. PubMed ID: 30667591
[TBL] [Abstract][Full Text] [Related]
4. Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study.
Langone A; Steinberg SM; Gedaly R; Chan LK; Shah T; Sethi KD; Nigro V; Morgan JC;
Clin Transplant; 2015 Sep; 29(9):796-805. PubMed ID: 26113208
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
[TBL] [Abstract][Full Text] [Related]
6. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2015 Oct; 54(10):993-1025. PubMed ID: 26038096
[TBL] [Abstract][Full Text] [Related]
7. Once-daily LCP-Tacro MeltDose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantations.
Grinyó JM; Petruzzelli S
Expert Rev Clin Immunol; 2014 Dec; 10(12):1567-79. PubMed ID: 25407098
[TBL] [Abstract][Full Text] [Related]
8. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.
Rostaing L; Bunnapradist S; Grinyó JM; Ciechanowski K; Denny JE; Silva HT; Budde K;
Am J Kidney Dis; 2016 Apr; 67(4):648-59. PubMed ID: 26717860
[TBL] [Abstract][Full Text] [Related]
9. Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial.
Budde K; Bunnapradist S; Grinyo JM; Ciechanowski K; Denny JE; Silva HT; Rostaing L;
Am J Transplant; 2014 Dec; 14(12):2796-806. PubMed ID: 25278376
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study.
Kamar N; Cassuto E; Piotti G; Govoni M; Ciurlia G; Geraci S; Poli G; Nicolini G; Mariat C; Essig M; Malvezzi P; Le Meur Y; Garrigue V; Del Bello A; Rostaing L
Adv Ther; 2019 Feb; 36(2):462-477. PubMed ID: 30552587
[TBL] [Abstract][Full Text] [Related]
11. Significant reduction of Tacrolimus trough level after conversion from twice daily Prograf to once daily Advagraf in Chinese renal transplant recipients with or without concomitant diltiazem treatment.
Ma MK; Kwan LP; Mok MM; Yap DY; Tang CS; Chan TM
Ren Fail; 2013 Aug; 35(7):942-5. PubMed ID: 23815459
[TBL] [Abstract][Full Text] [Related]
12. Modified release tacrolimus.
First MR; Fitzsimmons WE
Yonsei Med J; 2004 Dec; 45(6):1127-31. PubMed ID: 15627307
[TBL] [Abstract][Full Text] [Related]
13. Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen.
Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR
Transplant Proc; 2005 Mar; 37(2):867-70. PubMed ID: 15848559
[TBL] [Abstract][Full Text] [Related]
14. LCPT once-daily extended-release tacrolimus tablets versus twice-daily capsules: a pooled analysis of two phase 3 trials in important de novo and stable kidney transplant recipient subgroups.
Bunnapradist S; Rostaing L; Alloway RR; West-Thielke P; Denny J; Mulgaonkar S; Budde K
Transpl Int; 2016 May; 29(5):603-11. PubMed ID: 26953629
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic Study of Conversion Between 2 Formulations of Once-daily Extended-release Tacrolimus in Stable Lung Transplant Patients.
Sintes H; Sáez-Giménez B; Berastegui C; López-Meseguer M; Monforte V; Bravo C; Vima J; Gómez-Ollés S; Roman A
Transplantation; 2018 Oct; 102(10):e439-e446. PubMed ID: 29965950
[TBL] [Abstract][Full Text] [Related]
16. Conversion of stable liver transplant recipients from a twice-daily Prograf-based regimen to a once-daily modified release tacrolimus-based regimen.
Florman S; Alloway R; Kalayoglu M; Lake K; Bak T; Klein A; Klintmalm G; Busque S; Brandenhagen D; Lake J; Wisemandle K; Fitzsimmons W; First MR
Transplant Proc; 2005 Mar; 37(2):1211-3. PubMed ID: 15848672
[TBL] [Abstract][Full Text] [Related]
17. Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients.
Comuzzi C; Lorenzin D; Rossetto A; Faraci MG; Nicolini D; Garelli P; Bresadola V; Toniutto P; Soardo G; Baroni GS; Adani GL; Risaliti A; Baccarani U
Transplant Proc; 2010 May; 42(4):1320-1. PubMed ID: 20534291
[TBL] [Abstract][Full Text] [Related]
18. Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation.
Iaria G; Sforza D; Angelico R; Toti L; de Luca L; Manuelli M; Bellini I; Manzia TM; Anselmo A; Tisone G
Transplant Proc; 2011 May; 43(4):1028-9. PubMed ID: 21620043
[TBL] [Abstract][Full Text] [Related]
19. Conversion from twice-daily to once-daily extended-release tacrolimus in renal transplant recipients: 2-year results and review of the literature.
Tran D; Vallée M; Collette S; Senécal L; Lafrance JP; Dandavino R; Boucher A
Exp Clin Transplant; 2014 Aug; 12(4):323-7. PubMed ID: 24844288
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis for optimizing the modified release tacrolimus (Advagraf) after kidney transplantation: A prospective randomized trial.
Bakr MA; Nagib AM; Donia AF; Denewar AA; Abu-Elmagd MM; Abbas MH; Abdel-Rahman AM; Mashaly ME; Elsaftawy MM; Ghoneim MA
Saudi J Kidney Dis Transpl; 2018; 29(6):1267-1273. PubMed ID: 30588956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
